Computational fragment-based screening using RosettaLigand: the SAMPL3 challenge

被引:15
作者
Kumar, Ashutosh [1 ]
Zhang, Kam Y. J. [1 ]
机构
[1] RIKEN, Zhang Initiat Res Unit, Adv Sci Inst, Wako, Saitama 3510198, Japan
关键词
Fragment based drug design; Molecular docking; Receptor flexibility; Partial charges; Scoring function; AUTOMATED DOCKING; PRACTICAL ASPECTS; PDBBIND DATABASE; SCORING FUNCTION; LIGAND DOCKING; SIDE-CHAIN; INHIBITOR; DISCOVERY; PROTEINS; CONFORMATIONS;
D O I
10.1007/s10822-011-9523-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SAMPL3 fragment based virtual screening challenge provides a valuable opportunity for researchers to test their programs, methods and screening protocols in a blind testing environment. We participated in SAMPL3 challenge and evaluated our virtual fragment screening protocol, which involves RosettaLigand as the core component by screening a 500 fragments Maybridge library against bovine pancreatic trypsin. Our study reaffirmed that the real test for any virtual screening approach would be in a blind testing environment. The analyses presented in this paper also showed that virtual screening performance can be improved, if a set of known active compounds is available and parameters and methods that yield better enrichment are selected. Our study also highlighted that to achieve accurate orientation and conformation of ligands within a binding site, selecting an appropriate method to calculate partial charges is important. Another finding is that using multiple receptor ensembles in docking does not always yield better enrichment than individual receptors. On the basis of our results and retrospective analyses from SAMPL3 fragment screening challenge we anticipate that chances of success in a fragment screening process could be increased significantly with careful selection of receptor structures, protein flexibility, sufficient conformational sampling within binding pocket and accurate assignment of ligand and protein partial charges.
引用
收藏
页码:603 / 616
页数:14
相关论文
共 60 条
  • [1] Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking
    Anderson, AC
    O'Neil, RH
    Surti, TS
    Stroud, RM
    [J]. CHEMISTRY & BIOLOGY, 2001, 8 (05): : 445 - 457
  • [2] [Anonymous], 2010, MOL OP ENV MOE VERS
  • [3] Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
    Artis, Dean R.
    Lin, Jack J.
    Zhang, Chao
    Wang, Weiru
    Mehra, Upasana
    Perreault, Mylene
    Erbe, David
    Krupka, Heike I.
    England, Bruce P.
    Arnold, James
    Plotnikov, Alexander N.
    Marimuthu, Adhirai
    Nguyen, Hoa
    Will, Sarah
    Signaevsky, Maxime
    Kral, John
    Cantwell, John
    Settachatgull, Calvin
    Yan, Douglas S.
    Fong, Daniel
    Oh, Angela
    Shi, Shenghua
    Womack, Patrick
    Powell, Benjamin
    Habets, Gaston
    West, Brian L.
    Zhang, Kam Y. J.
    Milburn, Michael V.
    Vlasuk, George P.
    Hirth, K. Peter
    Nolop, Keith
    Bollag, Gideon
    Ibrahim, Prabha N.
    Tobin, James F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (01) : 262 - 267
  • [4] Deconstructing fragment-based inhibitor discovery
    Babaoglu, Kerim
    Shoichet, Brian K.
    [J]. NATURE CHEMICAL BIOLOGY, 2006, 2 (12) : 720 - 723
  • [5] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [6] Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
    Bollag, Gideon
    Hirth, Peter
    Tsai, James
    Zhang, Jiazhong
    Ibrahim, Prabha N.
    Cho, Hanna
    Spevak, Wayne
    Zhang, Chao
    Zhang, Ying
    Habets, Gaston
    Burton, ElizabethA.
    Wong, Bernice
    Tsang, Garson
    West, Brian L.
    Powell, Ben
    Shellooe, Rafe
    Marimuthu, Adhirai
    Nguyen, Hoa
    Zhang, Kam Y. J.
    Artis, Dean R.
    Schlessinger, Joseph
    Su, Fei
    Higgins, Brian
    Iyer, Raman
    D'Andrea, Kurt
    Koehler, Astrid
    Stumm, Michael
    Lin, Paul S.
    Lee, Richard J.
    Grippo, Joseph
    Puzanov, Igor
    Kim, Kevin B.
    Ribas, Antoni
    McArthur, Grant A.
    Sosman, Jeffrey A.
    Chapman, Paul B.
    Flaherty, Keith T.
    Xu, Xiaowei
    Nathanson, Katherine L.
    Nolop, Keith
    [J]. NATURE, 2010, 467 (7315) : 596 - 599
  • [7] In pursuit of virtual lead optimization: The role of the receptor structure and ensembles in accurate docking
    Bolstad, Erin S. D.
    Anderson, Amy C.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 73 (03) : 566 - 580
  • [8] Systematic Exploitation of Multiple Receptor Conformations for Virtual Ligand Screening
    Bottegoni, Giovanni
    Rocchia, Walter
    Rueda, Manuel
    Abagyan, Ruben
    Cavalli, Andrea
    [J]. PLOS ONE, 2011, 6 (05):
  • [9] A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
    Card, GL
    Blasdel, L
    England, BP
    Zhang, C
    Suzuki, Y
    Gillette, S
    Fong, D
    Ibrahim, PN
    Artis, DR
    Bollag, G
    Milburn, MV
    Kim, SH
    Schlessinger, J
    Zhang, KYJ
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (02) : 201 - 207
  • [10] Molecular docking and ligand specificity in fragment-based inhibitor discovery
    Chen, Yu
    Shoichet, Brian K.
    [J]. NATURE CHEMICAL BIOLOGY, 2009, 5 (05) : 358 - 364